Methylation Profile of Small Breast Cancer Tumors Evaluated by Modified MS–HRM

The DNA methylation profile of breast cancer differs from that in healthy tissues and can be used as a diagnostic and prognostic biomarker. Aim of this study: To compare the levels of gene methylation in small malignant breast cancer tumors (<2 cm), in healthy tissue, and in fibroadenoma, and to...

Descripción completa

Detalles Bibliográficos
Autores principales: Krasnyi, Aleksey M., Sadekova, Alsu A., Kometova, Vlada V., Rodionov, Valeriy V., Yarotskaya, Ekaterina L., Sukhikh, Gennadiy T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454410/
https://www.ncbi.nlm.nih.gov/pubmed/37628841
http://dx.doi.org/10.3390/ijms241612660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454410/
https://www.ncbi.nlm.nih.gov/pubmed/37628841
http://dx.doi.org/10.3390/ijms241612660

Ejemplares similares